By 2030, it is anticipated that the Thailand Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30. The market is primarily dominated by local players such as Siam Pharmaceuticals, Thai Nakorn Patana, and Bangkok Dusit Medical Services. The market is driven by the prevalence of dermatology conditions, awareness about dermatological health, and medical tourism. The dermatology drug market in Thailand is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
By 2030, it is anticipated that the Thailand Dermatology drugs market will reach a value of $xx Mn from $xx Mn in 2022, growing at a CAGR of xx% during 2022-30.
In Thailand, the prevalence of dermatological disease was 7% of the total population in 2018. Dermatitis, bacterial skin diseases, and urticaria were the most prevalent skin conditions treated by Thailand's healthcare services, with prevalence rates of 2.35%, 2.21%, and 0.89%, respectively.
Due to the rapid rise in demand for medical services and medications since Thailand's Universal Coverage Scheme was first implemented in 2002, the Thai government dedicates roughly 13.3% of its total budget to public health services. The latest WHO data show that 3,375 deaths from skin diseases, or 0.76% of all deaths, occurred in Thailand in 2020. In 2019, the Thai government spent 3.8% of its GDP on healthcare.
Market Growth Drivers
Thailand is regarded as one of the most competitive locations in the world for receiving high-quality healthcare at an affordable price. Only about one-fifth as much is spent on healthcare in Thailand as it is in the US and Europe. Based on costs and the appeal of the location, the International Healthcare Research Center ranked Thailand's medical tourism sector sixth globally in 2016. The dermatology sector of Thailand's pharmaceutical industry has been actively encouraged to grow by the Thai government.
Market Restraints
The level of research and development investment in the dermatology drugs market in Thailand is relatively low, which can limit the development of new and innovative treatments.
Key Players
The regulatory body for dermatology drugs in Thailand is the Food and Drug Administration (FDA) under the Ministry of Public Health. The FDA is in charge of ensuring the security, caliber, and effectiveness of all pharmaceuticals and cosmetics sold in Thailand, including dermatology medications.
Thailand's universal health care (UHC) system provides basic medical care to all of its residents. It covers the expenses of OPD consultations for dermatological conditions such as psoriasis, eczema, pruritus, and so on.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The Dermatology Drugs Market is segmented as mentioned below
By Disease (Revenue, USD Billion):
By Route Of Administration (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.